Is perineural invasion more accurate than other factors to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma?

World Journal of Surgery

Volumn 38, Issue 8, 2014, Pages 2132-2137

  Fouquet, Thibaut ^a   Germain, Adeline ^a   Brunaud, Laurent ^a   Bresler, Laurent ^a   Ayav, Ahmet ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADENOCARCINOMA; ADULT; AGED; BLOOD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATHOLOGY; PERIPHERAL NERVE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PERIPHERAL NERVES; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84903759573     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2465-7     Document Type: Article

References (23)

1. Trede M, Schawall G, Saeger HD (1990) Survival after pancreaticoduodenectomy. 118 Consecutive resections without an operative mortality. Ann Surg 211:447-458 (Pubitemid 20138186)
2. Yeo CJ, Cameron JL, Sohn TA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications and outcomes. Ann Surg 226:248-257 (Pubitemid 28070917)
3. Nitecki SS, Sarr MG, Colby TV et al (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59-66
4. Moreaux J, Catala M, Marzano L (1984) Results of the surgical treatment of pancreatic cancer. Study of a series of 96 surgically treated patients. Gastroenterol Clin Biol 8:11-16 (Pubitemid 14182361)
5. Magistrelli P, Antinori A, Crucitti A et al (2000) Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74:36-40 (Pubitemid 30387220)
6. Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267-277 (Pubitemid 46143304)
7. Neoptolemos JP, Moore MJ, Cox TF et al (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308:147-156
8. Kim EJ, Ben-Jospef E, Herman JM et al (2013) A multi-institutional phase 2 study of neo adjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer 119:2692-2700
9. Zhang Y, Adam EF, Kyriakides C et al (2012) Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemotherapy. J Cancer Res Clin Oncol 138:1063-1071
10. Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165-174
11. Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB (Oxf) 11:282-289
12. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and result of Survey. Ann Surg 240:205-213 (Pubitemid 38963009)
13. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8-13 (Pubitemid 40933766)
14. Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761-768 (Pubitemid 350018837)
15. Hartwig W, Hackert T, Hinz U et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311-319
16. Helm J, Centeno BA, Coppola D et al (2009) Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Cancer 115:4080-4089
17. Jentzer A (1930) Neurotropisme des cellules cancéreuses: clinique et thérapeutique des cancers neurotropes. Schweiz Med Wochenschr 60:1050-1052
18. Obyama K (1984) Clinicopathologic study on resected cases of carcinoma of the pancreas: prognosis and lymphatic metastasis. Jpn J Surg 85:820-834
19. Chen JW, Bhandari M, Astill DS et al (2010) Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. HPB (Oxf) 12:101-108
20. Shimada K, Nara S, Esaki M et al (2011) Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas 40:464-468
21. Neoptolemos JP, Stocken DD, Bassi C et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073-1081
22. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817-1825
23. Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337-1344